| __timestamp | Neurocrine Biosciences, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17986000 | 1499100000 |
| Thursday, January 1, 2015 | 32480000 | 1923500000 |
| Friday, January 1, 2016 | 68081000 | 2351400000 |
| Sunday, January 1, 2017 | 169906000 | 2564000000 |
| Monday, January 1, 2018 | 248932000 | 2397300000 |
| Tuesday, January 1, 2019 | 354100000 | 2503400000 |
| Wednesday, January 1, 2020 | 433300000 | 3344600000 |
| Friday, January 1, 2021 | 583300000 | 4529200000 |
| Saturday, January 1, 2022 | 752700000 | 4179100000 |
| Sunday, January 1, 2023 | 887600000 | 4650100000 |
| Monday, January 1, 2024 | 1007200000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, effective cost management is crucial. Neurocrine Biosciences, Inc. and Viatris Inc. offer a compelling study in contrasts over the past decade. From 2014 to 2023, Neurocrine's Selling, General, and Administrative (SG&A) expenses surged by nearly 4,800%, reflecting its aggressive growth strategy. Meanwhile, Viatris Inc. maintained a more stable trajectory, with a 210% increase, underscoring its focus on operational efficiency.
These trends reveal strategic priorities and market positioning, offering valuable insights for investors and industry analysts alike.
Who Optimizes SG&A Costs Better? Sanofi or Neurocrine Biosciences, Inc.
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Neurocrine Biosciences, Inc.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Neurocrine Biosciences, Inc.
Comparing SG&A Expenses: Neurocrine Biosciences, Inc. vs Catalent, Inc. Trends and Insights
Neurocrine Biosciences, Inc. vs Bio-Techne Corporation: SG&A Expense Trends
Breaking Down SG&A Expenses: Neurocrine Biosciences, Inc. vs Rhythm Pharmaceuticals, Inc.
Neurocrine Biosciences, Inc. and Mesoblast Limited: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Neurocrine Biosciences, Inc. vs Novavax, Inc.
SG&A Efficiency Analysis: Comparing Viatris Inc. and Blueprint Medicines Corporation
Comparing SG&A Expenses: Viatris Inc. vs ACADIA Pharmaceuticals Inc. Trends and Insights
Selling, General, and Administrative Costs: Viatris Inc. vs Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Galapagos NV